If you need a more accessible version of this website, click this button on the right. Switch to Accessible Site

WARNING

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close [x]

Current Clinical Trials

Canine Osteosarcoma Vaccine, Live Listeria Vector (COV-LLV)

Our Culver City office is participating in a study to evaluate the Canine Osteosarcoma Vaccine, Live Listeria Vector (COV-LLV), a conditionally licensed product for dogs with osteosarcoma who have undergone amputation and chemotherapy. For participation, your dog must meet the eligibility requirements listed in the study protocol. Your veterinarian will confirm eligibility by reviewing your dog’s medical history, performing a physical exam, taking thoracic radiographs, and submitting routine blood and urine testing. All dogs enrolled in the study will be treated with the immunotherapy.

If you have any questions or are interested in discussing the trial, please email us at LA.info@vetcancergroup.com with the subject line "COV-LLV Question" or call our Culver City office at (310) 558-6120 and ask to speak with trial aides Josef or Melissa.

(Prior to acceptance into any trial, all candidates are required to have a consultation to determine eligibility. The fee for the consultation is the responsibility of the pet owner.)

Visit this link for more information about current pet clinical trials:
American Veterinary Medical Association's Animal Health Studies Database.

(edited June 2018)

Go to top of page